NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Excuses! Eden is not needed for reimbursement. Period. Of course, it will be needed to scale manufacturing in the future and to bring the costs down, but that shouldn’t hold up reimbursement evidence submission. They are totally separate. If LP or LG gives that as a reason for not submitting reimbursement evidence then she is going to get sued.

Eden will also need a ton of cash upfront to deploy once its certified for commercial manufacturing which is highly unlikely until mid 2026 at the earliest. And don’t forget the COGs for each Eden unit, it’s not going to be cheap to equip multiple Eden units.

I certainly plan to check in with you every quarter on your $90M annual revenue projection during the first year of UK approval! ;) My forecast is less than $15M in annual revenue for NWBO.